Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The incidence and prevalence of multiple sclerosis in nova scotia, Canada.
Involvement of Toso in activation of monocytes, macrophages, and granulocytes.
Superior temporal gyrus thickness correlates with cognitive performance in multiple sclerosis.
Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica.
Multiple sclerosis and inflammatory bowel diseases: what we know and what we would need to know!
Gilenya Safety Update
Clinical associations between gout and multiple sclerosis, Parkinson's disease and motor neuron disease: record-linkage studies.
Optimizing therapy early in multiple sclerosis: An evidence-based view.
[Changes of epidemiological and clinical features and disease concept in multiple sclerosis].
Multiple sclerosis and infections.
Cigarette smoking and associated risk of multiple sclerosis in the Iranian population.
Caregiver burden, quality of life and walking ability in different disability levels of multiple sclerosis.
Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells.
Liposome-encapsulated peptides protect against experimental allergic encephalitis.
Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway.
Industry Update: The latest developments in therapeutic delivery.
[Immunomodulatory properties of stem mesenchymal cells in autoimmune diseases.]
Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system.
Interpreting therapeutic effect in multiple sclerosis via MRI contrast enhancing lesions: now you see them, now you don't.
Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis.
Fingolimod does not impair T-cell release from the thymus and beneficially affects Treg function in patients with multiple sclerosis.
Voxel-wise mapping of cervical cord damage in multiple sclerosis patients with different clinical phenotypes.
Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines.
Progressive multifocal leukoencephalopathy: cavitary white matter lesions.
[Chronic cough and worsening dyspnea: a case of idiopathic tracheal stenosis].
Pages
« first
‹ previous
…
373
374
375
376
377
378
379
380
381
…
next ›
last »